| Authors: |
O'Hara MH; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Jegede O; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Dickson MA; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York., DeMichele AM; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Piekarz R; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Gray RJ; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Wang V; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Onitilo A; Marshfield Medical Center - Weston, Weston, Wisconsin., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Arteaga CL; UT Southwestern Simmons Cancer Center, Dallas, Texas., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., O'Dwyer PJ; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Chen AP; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. |
